Another hallmark of CCMs is the cleavage of the matrix proteoglycan versican by the metalloprotease ADAMTS-4, leading to the exposure of the neo-epitope DPEAAE43. This evidence concerns the gene ADAMTS4 and cerebrocostomandibular syndrome.